Experimental chemotherapy in leprosy, then and now.
D000083:Acetanilides / Q000627:therapeutic use; D000818:Animals; D001419:Bacteria / Q000378:metabolism; D002509:Cephaloridine / Q000627:therapeutic use; D002991:Clofazimine / Q000494:pharmacology / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D049672:History, 19th Century; D006801:Humans; D007918:Leprosy / Q000188:drug therapy / Q000266:history; D008322:Mammals / Q000378:metabolism; D009166:Mycobacterium leprae / Q000187:drug effects; D009167:Mycobacterium lepraemurium / Q000187:drug effects; D009821:Oils / Q000627:therapeutic use; D011247:Pregnancy; D012293:Rifampin / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000494:pharmacology / Q000627:therapeutic use; D013828:Thioacetazone / Q000009:adverse effects / Q000627:therapeutic use; D013890:Thiourea / Q000494:pharmacology / Q000627:therapeutic use
D000083:Acetanilides; D009821:Oils; D013449:Sulfonamides; D013450:Sulfones; D013412:Sulfadimethoxine; D003622:Dapsone; D002991:Clofazimine; D013890:Thiourea; D002509:Cephaloridine; D013828:Thioacetazone; D005000:Ethionamide; D012293:Rifampin